FDA NDC Directory · JSON-LD · Markdown

Pradaxa

NDC 0597-0435 · HUMAN PRESCRIPTION DRUG · PELLET

Generic namedabigatran etexilate
Labeler / ManufacturerBoehringer Ingelheim Pharmaceuticals, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA214358
Dosage form / routePELLET · ORAL
Active ingredientsDABIGATRAN ETEXILATE MESYLATE (40 mg/1)
Marketing started20220316
Package count1

External sources

Source: openFDA. Public-domain (CC0).